FAQ/Help |
Calendar |
Search |
Today's Posts |
04-28-2014, 12:23 PM | #1 | ||
|
|||
Magnate
|
hopefully phase3 will be soon and minimal side affects.! quicker acting l-dopa that bypasses the digestive system will be a god send imho, even if i have a huge copay . i assume will still have to worry about amino acid interference getting thru BBB but at least won't be worrying about gastric emptying.
http://www.businesswire.com/news/hom...s#.U16M-FeHgYI |
||
Reply With Quote |
"Thanks for this!" says: | Tupelo3 (04-28-2014) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Hisamitsu announces positive Phase II results for Parkinson’s disease drug | Parkinson's Disease | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
inhaled l-dopa - Civitas starts Phase 2a trial of Parkinson’s treatment | Parkinson's Disease | |||
NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Pa | Parkinson's Disease | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease |